Found 15 matching trials
Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell Carcinoma PHASE2 This is a phase 2, open-label, single-arm clinical trial evaluating neoadju...
Show More Location
Hospital of Stomatology, Sun Yat-sen University
Learn More & Join Trial
A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC PHASE2 This study is conducted in patients with Locally advanced, unresectable, or...
Show More Location
Cancer Hospital Chinese Academic of Medical Sciences
Learn More & Join Trial
Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer PHASE2 This open-label, multicenter, randomized, controlled, Phase II study is pla...
Show More Location
Arizona Clinical Research Center
Learn More & Join Trial
A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive Mutations PHASE3 This is a Phase 3, randomized, positive-controlled, open-label clinical stu...
Show More Location
Sun Yat sen University Cancer Prevention and Treatment Center
Learn More & Join Trial
HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors PHASE1 This Phase1, open-label and dose-escalation study will evaluate the safety,...
Show More Location
Fudan University shanghai cancer center
Learn More & Join Trial
HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular Carcinoma PHASE2 This study is conducted in patients with advanced hepatocellular carcinoma ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer PHASE1 The main purpose of this study is to test the safety and tolerability and e...
Show More Location
The Royal Marsden Hospital
Learn More & Join Trial
Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer PHASE2 The purpose of this study is to compare the effectiveness and safety of exp...
Show More Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of HLX07 in nsqNSCLC Patients With High EGFR Expression PHASE2 An Open-label, Multicenter , Phase II Clinical Study to Evaluate the Effica...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer PHASE2 This study is conducted in patients with advanced metastatic small cell lun...
Show More Location
Jilin Cancer Hospital
Learn More & Join Trial